Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Applying a specific inhibitor lightens skin and hair color.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Tofacitinib is an effective and safe treatment for alopecia areata.